As the gut microbiota and the brain are well connected via the so-called gut–brain axis, manipulation of GLP-1 receptors in areas of the brain might represent a valuable pharmacological strategy to treat obesity by influencing food intake, satiety, and thus, body weight control [316,317]. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.